RESILIENCE GOVERNMENT SERVICES, INC.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1999-01-01
- Employees
- 251
- Market Cap
- -
- Website
- https://www.ologybio.com
Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
- Conditions
- Influenza
- Interventions
- Biological: Whole virion, Vero cell-derived influenza vaccine containing either 3.75 µg or 7.5 µg H5N1 hemagglutinin (HA) antigen in a non-adjuvanted formulation
- First Posted Date
- 2007-08-17
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT00517517
- Locations
- ðŸ‡ðŸ‡°
University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong
ðŸ‡ðŸ‡°Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
🇸🇬National University Hospital, Singapore, Singapore
Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
- Conditions
- Influenza
- Interventions
- Biological: Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 550
- Registration Number
- NCT00462215
- Locations
- 🇦🇹
University Hospital, Department of Clinical Pharmacology, General Hospital Vienna, Vienna, Austria
🇩🇪University Hospital Mainz, Mainz, Germany
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)
- Conditions
- Influenza
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 1000
- Registration Number
- NCT00424086
- Locations
- 🇦🇹
Kinemed, Graz, Austria
🇩🇪MDS Pharma Services Germany GmbH, Hamburg, Germany
🇩🇪Harrison Clinical Research, Munich, Germany
Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
- Conditions
- Influenza
- First Posted Date
- 2006-07-06
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT00349141
- Locations
- 🇦🇹
University Hospital, Department of Clinical Pharmacology, General Hospital Vienna, Vienna, Austria
🇸🇬National University Hospital, Singapore, Singapore
🇸🇬Changi General Hospital, Singapore, Singapore
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)
- Conditions
- Influenza
- First Posted Date
- 2006-02-10
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 423
- Registration Number
- NCT00289510
- Locations
- 🇦🇹
Allgemeines Krankenhaus Wien (General Hospital Vienna), Vienna, Austria
🇩🇪Klinikum Westend, Haus 18, Berlin, Germany
🇩🇪Internistische Gemeinschaftspraxis Dr. Regner & Dr. Schmitt (Group practice for internal medicine), Mainz, Germany
Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004
- Conditions
- Influenza
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Registration Number
- NCT00161837
- Locations
- 🇵🇱
PANTAMED Sp.z o.o., Olsztyn, Poland
Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005
- Conditions
- Influenza
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 1400
- Registration Number
- NCT00161811
- Locations
- 🇦🇹
Vienna General Hospital (AKH), Department of Clinical Pharmacology, Vienna, Austria
🇩🇪Neuendorfstr. 20, Henningsdorf, Germany
🇩🇪Münstererstr. 1a, Mainz, Germany